GeneQuine
Develops novel therapies for osteoarthritis, a degenerative joint disease with high unmet medical need.
Launch date
Employees
Market cap
-
Enterprise valuation
€22—32m (Dealroom.co estimates Jan 2021.)
Company register number HRB 124958 (Hamburg)
Hamburg Germany (HQ)
Authorizing premium user...